Company
AmeriPath
Bigger. Better. Specialized. Learn more
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
AmeriPath is one of the largest anatomic pathology and dermatopathology laboratories in the country. Principals of CHL participated in the growth buyout of AmeriPath. The company grew substantially leading up to its initial public offering (NASDAQ: PATH). The company was subsequently acquired by a financial buyer for $840 million is now owned by Quest Diagnostics.
Loading relationship preview